Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
Heterologous Effects of Vaccines
About this trial
This is an interventional basic science trial for Heterologous Effects of Vaccines
Eligibility Criteria
Inclusion Criteria:
- Two study groups 30-50 years old >65 years old
Exclusion Criteria:
- Unwell on day of vaccination
- Temperature >38°C
- Active cancer
- Active autoimmune disease
- Diabetes mellitus
- Taking immunosuppressive drugs including steroids
- Any vaccination in last 3 months
- DT or DTaP vaccination in the last year
- Known allergy or contraindication to influenza or DTaP vaccination
- Pregnant or breastfeeding
Sites / Locations
- Clifford Craig FoundationRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Group 1
Group 2
Group 3
Diphtheria-tetanus-acellular pertussis vaccine administered day 0, followed by seasonal influenza vaccination four weeks later. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week, 4 weeks, 4 weeks + 24 hours, 5 weeks, 8 weeks and 30 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.
Seasonal influenza vaccine administered on day 0, to be offered DTP vaccine at week 26. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week 1, 4 weeks and 26 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.
Seasonal influenza vaccine and DTP vaccine administered together on day 0. Blood testing to occur day 0 (prior to vaccine administration), 24 hours, 1 week 1, 4 weeks and 26 weeks. Stool samples to be taken at day 0 and 1 week post-vaccination.